Latest Transplantation News

"Stem Cells Market Will Reach $7.3 Billion in 2014," Visiongain Report PredictsLondon, United Kingdom, May 26, 2012 --(PR.com)-- That market will be stimulated by new treatments and increasing use of related products in drug development. Those findings appear in Stem Cell Technologies: World Market Outlook 2012-2022, published in May 2012. Visiongain is a business information provider based in London, UK. Visiongain forecasts that the stem cells market will expand rapidly...

City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting Brain Tumor Stem CellsCity of Hope was granted a $5,217,004 early translational research award by the California Institute for Regenerative Medicine (CIRM) to support the development of a T cell-based immunotherapy that re-directs a patient’s own immune response against glioma stem cells. City of Hope has been awarded more than $49.7 million in grant support from CIRM since a...

Carl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft SurgeryCarl Zeiss Meditec AG / Carl Zeiss Presents Fluorescence Technology for Intraoperative Analysis of Blood Flow in Skin and Muscle Tissue Graft Surgery . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. INFRARED 800 and FLOW 800 Fluorescence Modules showcased at the upcoming EURAPS 2012 JENA/Germany, 25 May 2012The INFRARED 80...

UCLA Launches First Face Transplantation Program In Western U.S.LOS ANGELES, May 25, 2012 /PRNewswire-USNewswire/ --The UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation. "Facial transplantation offers the potential to restore humanity to persons who have suffered the devastating loss of their face," said Dr. Kodi Azari, chief of re...

UCLA Face Transplantation Program seeks candidates for clinical trialThe UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation.

Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United StatesCHENGDU, China, May 25, 2012 /PRNewswire-Asia/ -- Recently, Wang Qiao, the eight-year program student of Liver and Vascular Surgery of West China Hospital tutored under Yan Lynan, went to San Francisco to attend the 18th ILTS (International Liver Transplantation Society) annual meeting with the director of his department, Mr. Li Bo. (Photo: http://photos.prnewswire.com/prnh/20120525/CN13960) The...

Respiratory Function Improved In Lung Transplant Patients By AzithromycinResearchers in the United Kingdom have determined that azithromycin, a broad-spectrum antibiotic that also has anti-inflammatory properties, can be an effective treatment option for patients suffering from bronchiolitis obliterans syndrome (BOS), a l...

UPMC Presbyterian Shadyside Hospital Will Participate in Aetna’s Institutes of Excellence™ Transplant NetworkAetna (NYSE: AET) announced today that UPMC Presbyterian Shadyside Hospital has been designated as a participating facility in Aetna’s Institutes of Excellence™ Transplant Network. The Institutes of Excellence (IOE) is Aetna’s participating network for transplants and transplant-related services. The IOE is comprised of hospitals that...

Pulmonary Fibrosis Foundation Congratulates Helene Campbell On Her Organ And Tissue Donation Advocacy EffortsCanadian Double-Lung Transplant Recipient Receives Diamond Jubilee Medal from Canadian Prime Minister Harper CHICAGO, May 24, 2012 /PRNewswire-USNewswire/ -- In her first public appearance since her surgery, 21-year-old, double-lung transplant recipient Helene Campbell held a press conference today about her journey and work promoting organ donation. Yesterday the Canadian Prime Ministe...

Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation

Azithromycin can be effective treatment option for patients with BOSResearchers in the United Kingdom have determined that azithromycin, a broad-spectrum antibiotic that also has anti-inflammatory properties, can be an effective treatment option for patients suffering from bronchiolitis obliterans syndrome (BOS), a l...

UCLA launches first face transplantation program in western US(University of California - Los Angeles Health Sciences) The UCLA Health System has launched the UCLA Face Transplantation Program, the first surgical program of its kind in the western United States and one of only a handful in the nation.

HeartWare Announces Publication Of Results From U.S. Bridge-To-Transplant Clinical TrialFRAMINGHAM, Mass. and SYDNEY, May 23, 2012 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the publication of results from ADVANCE, the Company's U.S. clinical trial evaluating the use of the HeartWare...

Liver transplant outcomes improving in EuropeNEW YORK (Reuters Health) - Outcomes of liver transplantation for acute liver failure (ALF) in Europe have improved over two decades, according to a report online April 18th in the Journal of Hepatology.

Chronic pain is relieved by cell transplantation in lab studyChronic pain, by definition, is difficult to manage, but a new study shows how a cell therapy might one day be used not only to quell some common types of persistent and difficult-to-treat pain, but also to cure the conditions that give rise to them.

HeartWare International Receives CE Mark Addendum, Expanding Label to Include All Patients at Risk of Death From Refractory, End-Stage Heart FailureFRAMINGHAM, Mass., and SYDNEY, May 23, 2012 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it has received an expanded European label for long-term use of the HeartWare® Ventricular Assist System in all patie...

Veloxis Pharmaceuticals announces a restructuring of the company to support and strengthen strategic focus on LCP-Tacro™ and announces changes to managementHORSHOLM, Denmark, May 23, 2012 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that it contemplates restructuring the company's operations in order to fully focus its resources on the completion of the development and subsequent commercialization of LCP-Tacro™, Veloxis' product candidate for the prevention of organ rejection. It is planned that a discontin...

Insception Biosciences Inc. Proudly Announces FACT Accreditation TORONTO, ONTARIO -- (Marketwire) -- 05/23/12 -- Insception Cord Blood Program is proud to announce the achievement of FACT accreditation by demonstrating compliance with the NETCORD-FACT International Standards for Cord Blood Collection, Processing, Testing, Banking, Selection and Release. "Our commitment to the highest quality standards is demonstrated by achieving the voluntary FACT accreditat...

Study shows antibiotic improves respiratory function in lung transplant patients(American Thoracic Society) Researchers in the United Kingdom have determined that azithromycin, a broad-spectrum antibiotic that also has anti-inflammatory properties, can be an effective treatment option for patients suffering from bronchiolitis o...

Pre-transplantation iron chelation in patients with MDS or acute leukemia and iron overload undergoing myeloablative allo-SCT

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

University Hospitals Case Medical Center Surgical Oncologist Presents Promising Data for Novel Pancreatic Cancer VaccineCLEVELAND, May 22, 2012 /PRNewswire/ -- A novel pancreatic cancer vaccine shows promise in improving survival and represents a potential breakthrough in the treatment of this deadly disease. Jeffrey Hardacre, MD, of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine presented results of a Phase 2 clinical trial in patients w...

Kidney Function Deteriorates in Overweight DonorsOne year after transplantation, overweight donors experience a decrease in kidney function. Medscape Medical News

Prochymal - First Stem Cell Drug ApprovedFor the first time in history a stem cell drug has been approved for market authorization. Prochymal® (remestemcel-L) is also the first drug to be approved for the treatment of acute graft-vs-host disease (GvHD) in children, a devastating complicat...

Cardio Notes: Race a Factor in Transplants(MedPage Today) -- Hispanics and blacks have real, but different, disparities compared with whites when it comes to heart transplantation. Also this week, 'old' second-hand smoke and an interesting breakdown of marathon deaths.

0 1 2 3 4 ›»

buy Transplantation market research data and corporate reports now Advertisement